MTOR and osteosarcoma: A small molecule/kinase inhibitor screen of murine-derived osteosarcoma cell lines revealed activity in compounds (PIK-75, GSK2126458, and BEZ-235) targeting PI3K and mTOR and/or DNA-PK.